
Allantoin: Used to protect and soften mildly dry or irritated skin. Polyhydroxy Acids: Offers exfoliation through ingredients such as gluconolactone and lactobionic acid.


Consider in a gentle skin-protectant formula, without expecting scar removal.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
Can you use both?
A gentle pairing for sensitive skin: PHAs exfoliate lightly and allantoin soothes.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Conditions the outer skin: Allantoin supports comfort in protective formulas. The whole product matters: Repair claims need evidence for the actual formula.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Loosens surface cells: PHAs promote shedding in the outer skin. Helps bind water: Hydroxyl groups contribute to water binding.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Allantoin’s U.S. skin-protectant range is 0.5–2%. This is a labeled protective use, not a concentration proven to erase scars.
0.5–2%
U.S. skin-protectant range
Used in qualifying protective products for skin comfort. Cosmetic formulas may include allantoin without stating its percentage.
Choosing a strength: Choose a finished cream or ointment suited to the area. For scars, assess evidence for the whole treatment rather than allantoin alone.
Higher strengths: More allantoin is not established as a better scar treatment or a substitute for care of a nonhealing wound.
Formula matters: Allantoin is often one ingredient in a moisturizing blend. Benefits of a combination product cannot be assigned to allantoin alone.
PHA is a family name, not one ingredient or one standard strength. A clinical acne trial used 14% gluconolactone; that result cannot be transferred directly to lactobionic acid or mixed-PHA products.
14%
Studied gluconolactone lotion
An older controlled acne trial tested this specific formula. It does not establish the best percentage for all PHA skincare.
Choosing a strength: Check which PHA is listed, whether the product stays on or washes off, and whether it also contains other exfoliating acids.
Higher strengths: A PHA product can still irritate, particularly when combined with other acids. A high total-acid percentage is not a validated benefit rating.
Formula matters: The individual acid, acidity and base formula matter. A blended-acid percentage does not reveal the amount of each PHA.
Approximate windows, not promises.
First few weeksSkin may feel softer soon after use; relief depends on the formula.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksJudge hydration, comfort and whether dryness is recurring.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksPersistent cracking, itch or a rash needs reassessment.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsContinue if comfortable; hydration usually requires ongoing use.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsMoisturizing does not establish reversal of structural ageing or scars.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Usually comfortable; discontinue for a rash or persistent stinging.
Can still sting or cause a rash; sensitive skin does not guarantee tolerance.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Very little is absorbed through the skin and it has a long record of use, but this is a question for the doctor managing your pregnancy, not for a label.
Low-strength leave-on acids are generally considered acceptable; ask the clinician managing your pregnancy.
On the skin. The finished product delivers allantoin in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Contributes protective and conditioning effects in topical formulas; proposed repair pathways are mainly experimental.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers polyhydroxy acids in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. PHA ingredients promote surface exfoliation and may also bind water; individual acids and formulas differ.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Consider in a gentle skin-protectant formula, without expecting scar removal.
Skin-protectant use is recognized in the FDA monograph. The cited wound-healing experiment was in rats and cannot establish faster human wound healing or acne treatment.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
A 150-person trial tested 14% gluconolactone for acne. Evidence from that molecule or a mixed-acid serum does not establish identical effects for all PHAs.
Sources